GWW
78
2
OKE
80
2
BF.B
25
-3
HRB
59
-7
FCX
63
-4
WM
82
3
UAL
85
2
CSX
65
3
PNC
67
3
NOC
54
4
AVGO
42
-2
LB
82
19
URI
72
3
LYB
41
-2
ESS
65
5
LRCX
52
2
COST
66
6
SE
50
-5
HSY
34
3
MMC
64
4
GWW
78
2
OKE
80
2
BF.B
25
-3
HRB
59
-7
FCX
63
-4
WM
82
3
UAL
85
2
CSX
65
3
PNC
67
3
NOC
54
4
AVGO
42
-2
LB
82
19
URI
72
3
LYB
41
-2
ESS
65
5
LRCX
52
2
COST
66
6
SE
50
-5
HSY
34
3
MMC
64
4
Financhill
Back

MediciNova 10K Form

Sell
26

MNOV
MediciNova

Last Price:
1.53
Seasonality Move:
-4.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q MNOV/MediciNova Quarterly
2023-11-09 10Q MNOV/MediciNova Quarterly
2023-08-09 10Q MNOV/MediciNova Quarterly
2023-05-11 10Q MNOV/MediciNova Quarterly
2022-11-10 10Q MNOV/MediciNova Quarterly
2022-08-11 10Q MNOV/MediciNova Quarterly

Receive MNOV News And Ratings

See the #1 stock for the next 7 days that we like better than MNOV

MNOV Financial Statistics

Sales & Book Value

Annual Sales: $1M
Cash Flow: $-2.81M
Price / Cash Flow: 0
Annual Sales: $1.17
Price / Book: 1.31

Profitability

EPS (TTM): -0.16000
Net Income (TTM): $-8.16M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

MediciNova Earnings Forecast

Key MediciNova Financial Ratios

  • The Selling, General & Administrative Expenses for MNOV have been equal to 524.24% of Gross Profit Margin.
  • The Research & Development expenses have been 565.79% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 13 years.

MediciNova Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MNOV
CUSIP: 58468P
Website: medicinova.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MNOV Technical Analysis vs Fundamental Analysis

Sell
26
MediciNova (MNOV) is a Sell

Is MediciNova a Buy or a Sell?

  • MediciNova stock is rated a Sell
    The current MediciNova [MNOV] share price is $1.53. The Score for MNOV is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.